Technology News and Research

RSS

Researchers investigate whole-genome data to uncover new mutations for CAD risk

The Coronary ARtery DIsease Genome-wide Replication And Meta-Analysis (CARDIoGRAM) published in Circulation Cardiovascular Genetics, an American Heart Association journal consists of data from every published whole-genome study on genetic mutations in heart attack or CAD risk. Researchers are also pooling data from several unpublished genome-wide association studies to see if any new mutations can be uncovered.

6 Oct 2010

Optical technology shows potential for prescreening patients at high risk for lung cancer

Researchers from Northwestern University and NorthShore University HealthSystem (NorthShore) have developed a method to detect early signs of lung cancer by examining cheek cells in humans using pioneering biophotonics technology.

6 Oct 2010

Accuray receives SBIR grant to develop high-energy X-ray source for Homeland Security applications

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the company was awarded a $1 million Small Business Innovation Research (SBIR) grant by the U.S. Government to be used toward further development of a high-energy X-ray source for Homeland Security applications.

6 Oct 2010

Saneron receives grant to develop safety guidelines for transplanting HUBC cells in Alzheimer's disease

The National Institutes of Health has awarded a three-year, $2.6-million grant to the University of South Florida and Tampa-based biotechnology company Saneron-CCEL Therapeutics, Inc., to establish dosing and safety guidelines for transplanting human umbilical cord blood cells (HUBC) into animal models of Alzheimer's disease.

6 Oct 2010

Varian, IMRIS enter agreement to co-develop new MR-guided radiation therapy system for cancer

Varian Medical Systems, Inc., and IMRIS Inc. have concluded an agreement to co-develop an innovative new MR-guided radiation therapy system for use in treating a variety of cancers.

6 Oct 2010

Profectus BioSciences awarded $3.1M Fast Track SBIR grant to develop prophylactic vaccine against HIV

Profectus BioSciences, Inc., a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases, today announced the award of a Fast Track SBIR from the Division of AIDS, National Institutes of Health for $3.1M to support the development of the Company's Transition State Vaccine (TSV) technology for a prophylactic HIV Vaccine.

6 Oct 2010

Altravax receives two SBIR grants for antibody-inducing vaccines research on HIV-1

Altravax, Inc. announced today that it has been awarded two SBIR grants totaling $1.2 million from the NIH's National Institute of Allergy and Infectious Diseases for research on antibody-inducing vaccines for HIV-1.

6 Oct 2010

Isogenica, NovaBiotics to accelerate the development of peptide anti-infective technology

Isogenica Ltd, today announced that it has entered into a collaboration agreement with NovaBiotics, a leading clinical-stage biotechnology company to fast-track the development of NovaBiotic's platform peptide anti-infective technology.

6 Oct 2010

CCHIT certifies Allscripts Professional EHR Version 9.2

Allscripts announced today that Allscripts Professional™ EHR, Version 9.2 is 2011/2012 compliant and was certified as a Complete EHR on Sept. 30, 2010 by the Certification Commission for Health Information Technology (CCHIT®), an Office of the National Coordinator for Health Information Technology Authorized Testing and Certification Body (ONC-ATCB), in accordance with the applicable eligible provider certification criteria adopted by the Secretary of Health and Human Services.

5 Oct 2010

Apricus Bio raises over $9.3 million in securities offering

Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.

5 Oct 2010

Liquidia commences dosing in LIQ-001 Phase 1 trial for seasonal influenza

Liquidia Technologies, a privately held nanotechnology company developing particle-based vaccines and therapeutics, today announced the initiation of human dosing of its lead vaccine product candidate, LIQ-001, in a Phase 1 clinical trial. LIQ-001, the first in a pipeline of PRINT® vaccines, is being developed as a seasonal influenza vaccine for enhanced protection in the elderly and represents the company's migration from proof of concept to the clinical application of PRINT technology.

5 Oct 2010

ISTO announces completion of enrollment in NuQu Phase I clinical study for discogenic back pain

ISTO Technologies, Inc., an orthobiologics company with a cell-based platform for cartilage regeneration, announced today the completion of patient enrollment in the Phase I clinical study for NuQu™, an injectable formulation of juvenile chondrocytes designed for the treatment of discogenic back pain. The study included 15 patients enrolled at two clinical sites. All patients enrolled in the trial suffered from persistent discogenic back pain and disability despite undergoing previous traditional conservative therapy.

5 Oct 2010

DATATRAK receives consulting contract to provide clinical data management

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the award of a consulting contract with an existing global research-based biopharmaceutical client to provide clinical data management and trial design services.

5 Oct 2010

CLC bio publishes article for simulating de novo assemblies

In the inaugural edition of the Open Access Journal "Genes", scientists from CLC bio along with Michael M. Miyamoto from the University of Florida published an article with corresponding free software for simulating de novo assemblies.

5 Oct 2010

TMNG Global and Scientia Advisors partner to offer strategic consulting services for home health sector

TMNG Global a leading provider of professional services to the global communications, digital media, technology, and financial services industries, and Scientia Advisors, a global management consulting firm specializing in healthcare, life science, nutrition and biotechnology, today announced a partnership to offer strategic consulting services for the emerging home health sector.

5 Oct 2010

Preclinical data of Enzon's PEG-SN38 in pediatric neuroblastoma published in Clinical Cancer Research

Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.

5 Oct 2010

Intellect Neurosciences receives patent for Alzheimer's disease monoclonal antibody program

Intellect Neurosciences, Inc., a biopharmaceutical company with internal preclinical and clinical-stage pipelines, as well as multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a patent from the United States Patent and Trademark Office (USPTO) related to its internal Alzheimer's disease (AD) monoclonal antibody program.

5 Oct 2010

Technology News and Research

Researchers investigate whole-genome data to uncover new mutations for CAD risk

Optical technology shows potential for prescreening patients at high risk for lung cancer

Accuray receives SBIR grant to develop high-energy X-ray source for Homeland Security applications

Saneron receives grant to develop safety guidelines for transplanting HUBC cells in Alzheimer's disease

Varian, IMRIS enter agreement to co-develop new MR-guided radiation therapy system for cancer

Profectus BioSciences awarded $3.1M Fast Track SBIR grant to develop prophylactic vaccine against HIV

Altravax receives two SBIR grants for antibody-inducing vaccines research on HIV-1

Isogenica, NovaBiotics to accelerate the development of peptide anti-infective technology

CCHIT certifies Allscripts Professional EHR Version 9.2

Apricus Bio raises over $9.3 million in securities offering

Liquidia commences dosing in LIQ-001 Phase 1 trial for seasonal influenza

ISTO announces completion of enrollment in NuQu Phase I clinical study for discogenic back pain

DATATRAK receives consulting contract to provide clinical data management

CLC bio publishes article for simulating de novo assemblies

TMNG Global and Scientia Advisors partner to offer strategic consulting services for home health sector

Preclinical data of Enzon's PEG-SN38 in pediatric neuroblastoma published in Clinical Cancer Research

Intellect Neurosciences receives patent for Alzheimer's disease monoclonal antibody program

GE Healthcare launches first human cellular assay product

EUCODIS Bioscience, evocatal enter alliance to market industrial enzyme products

Ceremed's implantable polymer material receives Best New Technology for Spine Care award

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News